Eprodisate for the Treatment of Renal Disease in AA Amyloidosis.
Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, Lesnyak O, Puéchal X, Lachmann HJ, Obici L, Balshaw R, Garceau D, Hauck W, Skinner M, Eprodisate for AA Amyloidosis Trial Group. N Engl J Med. 2007 Jun 7;356(23):2349-60
Related Articles:
- The Case for Renal Artery Stenting for Treatment of Renal Artery Stenosis.
- Phosphate Metabolism in the Setting of Chronic Kidney Disease: Significance and Recommendations for Treatment.
- Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease.
Recent Comments